Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or misma...
Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study
About this item
Full title
Author / Creator
Yu, Jie-Hai, MD , Xiao, Bin-Yi, MD , Li, Dan-Dan, MD , Jiang, Wu, MD , Ding, Ya, MD , Wu, Xiao-Jun, MD , Zhang, Rong-Xin, MD , Lin, Jun-Zhong, MD , Wang, Wei, MD , Han, Kai, MD , Kong, Ling-Heng, MD , Zhang, Xin-Ke, MD , Chen, Bi-Yun , Mei, Wei-Jian, MD , Pan, Zhi-Zhong, MD , Tang, Jing-Hua, MD , Zhang, Xiao-Shi, MD and Ding, Pei-Rong, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
SummaryBackgroundPD-1 blockade is highly efficacious for mismatch repair-deficient colorectal cancer in both metastatic and neoadjuvant settings. We aimed to explore the activity and safety of neoadjuvant therapy with PD-1 blockade plus an angiogenesis inhibitor and the feasibility of organ preservation in patients with locally advanced mismatch re...
Alternative Titles
Full title
Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study
Authors, Artists and Contributors
Author / Creator
Xiao, Bin-Yi, MD
Li, Dan-Dan, MD
Jiang, Wu, MD
Ding, Ya, MD
Wu, Xiao-Jun, MD
Zhang, Rong-Xin, MD
Lin, Jun-Zhong, MD
Wang, Wei, MD
Han, Kai, MD
Kong, Ling-Heng, MD
Zhang, Xin-Ke, MD
Chen, Bi-Yun
Mei, Wei-Jian, MD
Pan, Zhi-Zhong, MD
Tang, Jing-Hua, MD
Zhang, Xiao-Shi, MD
Ding, Pei-Rong, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3066334429
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3066334429
Other Identifiers
ISSN
1470-2045,1474-5488
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(24)00203-1
